Surgical therapy of lung metastases is now an established procedure. T
he operation's purpose is radical, and therefore potentially curative,
resection. There are also diagnostic and palliative indications. Medi
an sternotomy is the standard approach as it allows revision of both l
ungs, which is important even when disease seems to be unilateral. Pre
operative staging does not give a reliable idea of the number and exte
nt of metastases. From 1972 to 1991, a total of 843 operations for lun
g metastases were carried out in 729 patients in the surgical departme
nt of the Thorax Clinic in Heidelberg (Rohrbach). The 30-day mortality
was 2.9%, and the overall 5-year survival from the date of resection
of the metastases was 33%. The best results were achieved in testicula
r cancer, with a 5-year-survival rate of 67%, and the poorest were obs
erved in melanomas, with only 12% 3-year survival. In addition to the
primary tumour, and in some cases depending on it, several other progn
ostic factors were relevant: radicality, sarcoma vs. carcinoma (carcin
oma involved a better prognosis), disease-free interval, type of resec
tion, thoracic lymph node involvement. Multivariate analysis showed th
at the prognostic influence of the factors varies considerably with th
e kind of primary tumour. Surgical treatment of lung metastases is par
t of an interdisciplinary oncological therapeutic concept offering pro
longation of survival to most of the patients concerned and even the p
ossibility of cure to some. Even if prolongation of survival is not fe
asible, an improved quality of life and therefore good palliation are
obtained.